DE69624214D1 - Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen - Google Patents

Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen

Info

Publication number
DE69624214D1
DE69624214D1 DE69624214T DE69624214T DE69624214D1 DE 69624214 D1 DE69624214 D1 DE 69624214D1 DE 69624214 T DE69624214 T DE 69624214T DE 69624214 T DE69624214 T DE 69624214T DE 69624214 D1 DE69624214 D1 DE 69624214D1
Authority
DE
Germany
Prior art keywords
ostrogen
deficiency
treating
hormonal drugs
hormonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69624214T
Other languages
English (en)
Other versions
DE69624214T2 (de
Inventor
Michel Lanquetin
Jacques Paris
Jean-Louis Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Theramex SAM
Original Assignee
Laboratoire Theramex SAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9481610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69624214(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire Theramex SAM filed Critical Laboratoire Theramex SAM
Application granted granted Critical
Publication of DE69624214D1 publication Critical patent/DE69624214D1/de
Publication of DE69624214T2 publication Critical patent/DE69624214T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69624214T 1995-08-01 1996-07-29 Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen Expired - Lifetime DE69624214T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509364A FR2737411B1 (fr) 1995-08-01 1995-08-01 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
PCT/IB1996/000754 WO1997004784A1 (fr) 1995-08-01 1996-07-29 Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques

Publications (2)

Publication Number Publication Date
DE69624214D1 true DE69624214D1 (de) 2002-11-14
DE69624214T2 DE69624214T2 (de) 2003-07-10

Family

ID=9481610

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69624214T Expired - Lifetime DE69624214T2 (de) 1995-08-01 1996-07-29 Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen

Country Status (31)

Country Link
US (1) US5891867A (de)
EP (1) EP0783310B1 (de)
JP (1) JPH10507207A (de)
KR (1) KR100450649B1 (de)
CN (1) CN1138547C (de)
AP (1) AP829A (de)
AR (1) AR004502A1 (de)
AT (1) ATE225659T1 (de)
AU (1) AU722355B2 (de)
BR (1) BR9606549A (de)
CA (1) CA2201368C (de)
CZ (1) CZ289706B6 (de)
DE (1) DE69624214T2 (de)
DK (1) DK0783310T3 (de)
DZ (1) DZ2078A1 (de)
ES (1) ES2184880T3 (de)
FR (1) FR2737411B1 (de)
HK (1) HK1005227A1 (de)
HU (1) HU229843B1 (de)
IL (1) IL120558A (de)
MA (1) MA23946A1 (de)
MX (1) MX9702381A (de)
MY (1) MY117307A (de)
NO (1) NO312996B1 (de)
OA (1) OA10411A (de)
PT (1) PT783310E (de)
RU (1) RU2188641C2 (de)
TN (1) TNSN96101A1 (de)
TW (1) TW473390B (de)
WO (1) WO1997004784A1 (de)
ZA (1) ZA966545B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
US20020151732A1 (en) * 2001-01-05 2002-10-17 Claes Ohlsson Estrogen receptors
WO2002092102A2 (en) * 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
WO2003049744A1 (en) * 2001-12-05 2003-06-19 Barr Laboratories, Inc. Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
AU2004257772B2 (en) * 2003-07-16 2009-12-17 Teva Women's Health, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
US8022053B2 (en) * 2004-11-02 2011-09-20 Bayer Schering Pharma Aktiengesellschaft Oral solid dosage forms containing a low dose of estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4826831A (en) * 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.

Also Published As

Publication number Publication date
HK1005227A1 (en) 1998-12-31
AR004502A1 (es) 1998-12-16
CZ96797A3 (cs) 1998-08-12
TW473390B (en) 2002-01-21
FR2737411B1 (fr) 1997-10-17
IL120558A0 (en) 1997-07-13
NO312996B1 (no) 2002-07-29
AU722355B2 (en) 2000-07-27
MX9702381A (es) 1998-02-28
HUP9900612A3 (en) 1999-11-29
JPH10507207A (ja) 1998-07-14
CN1167438A (zh) 1997-12-10
CA2201368C (fr) 2010-12-07
CA2201368A1 (fr) 1997-02-13
DE69624214T2 (de) 2003-07-10
EP0783310A1 (de) 1997-07-16
NO971449D0 (no) 1997-03-26
CN1138547C (zh) 2004-02-18
RU2188641C2 (ru) 2002-09-10
OA10411A (fr) 2001-12-06
FR2737411A1 (fr) 1997-02-07
US5891867A (en) 1999-04-06
NO971449L (no) 1997-05-30
KR970706004A (ko) 1997-11-03
BR9606549A (pt) 1998-06-23
DZ2078A1 (fr) 2002-10-22
KR100450649B1 (ko) 2004-11-16
TNSN96101A1 (fr) 2005-03-15
ATE225659T1 (de) 2002-10-15
ES2184880T3 (es) 2003-04-16
CZ289706B6 (cs) 2002-03-13
DK0783310T3 (da) 2003-02-10
HUP9900612A2 (hu) 1999-07-28
WO1997004784A1 (fr) 1997-02-13
AU6367496A (en) 1997-02-26
HU229843B1 (en) 2014-09-29
ZA966545B (en) 1997-05-08
IL120558A (en) 2002-09-12
AP9700979A0 (en) 1997-07-31
MA23946A1 (fr) 1997-04-01
EP0783310B1 (de) 2002-10-09
PT783310E (pt) 2003-02-28
MY117307A (en) 2004-06-30
AP829A (en) 2000-05-03

Similar Documents

Publication Publication Date Title
ATE349428T1 (de) Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen
DE69622074D1 (de) Cystin-Silikon-Copolymere und deren Verwendung zur Behandlung von keratinischen Materialien
DE69524402T2 (de) Arzneiabgabevorrichtung und deren konstruktionsmethode
DE69732225D1 (de) Verfahren zur Verkapselung von biologisch aktiven Stoffen in Erythrocyten und Gerät dafür
DE69723080D1 (de) Chirurgische implantate und deren anbringungssysteme
DE800382T1 (de) Zusammensetzungen zur behandlung von dermatologischen krankheiten und verfahren zu ihrer verwendung
DE29506194U1 (de) Fensterelement zur Abschirmung und Erhellung von Innenräumen
NO982913D0 (no) Kinolin- og kinazolinforbindelser nyttige i terapi
DE69820258D1 (de) Vorrichtung zur einstellung und fixierung von knochenbrüchen
DE69430694D1 (de) Wirbelsäulenbehandlung und apparatur zur wirbelsäulenrichtung
DE873126T1 (de) Markierte vitamin d-verbindungen und deren verwendung
DE69424640T2 (de) Filmbehandlungsmethode und System
ATE186447T1 (de) Zusammensetzung und verwendung
DE69610568D1 (de) Fixiervorrichtung und Film zur Verwendung in derselben
DE69624214D1 (de) Hormonale medikamente und deren verwendung zur behebung von östrogenmangelerscheinungen
DE69804659T2 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
DE59504023D1 (de) Vorrichtung und ihre verwendung zur oxichlorierung
DE69716896T2 (de) Substituierte benzylamine-derivate und ihre verwendung zur behandlung von depression
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69627515D1 (de) Material zur verleihung von nicht-klebenden und nicht-benetzenden eigenschaften
DE69832722D1 (de) L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen
ATE346840T1 (de) Aminoalkylphenol-derivate zur behandlung von depression und gedächtnis-funktionsstörung
DE69826460D1 (de) Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems
DE59611118D1 (de) Substituierte Tetrahydro-5-nitro-pyrimidine und deren Verwendung zur Bekämpfung von tierischen Schädlingen
DE69110861D1 (de) Mittel zur verbesserung des kollagenmetabolismus und dessen verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition